Could a pain reliever curb alcohol cravings? new study investigates
NCT ID NCT06636227
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests whether diclofenac, an FDA-approved painkiller, can reduce alcohol cravings in people with alcohol use disorder. Researchers believe diclofenac may work by shifting brain chemistry away from harmful effects of alcohol. The study involves 24 adults who will receive different doses of diclofenac or a placebo to measure changes in blood markers and cravings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER (AUD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Maryland Psychiatric Research Center
RECRUITINGCatonsville, Maryland, 21248, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a psychedelic compound help veterans and first responders with PTSD and alcohol use disorder?
- Zapping the brain to fight alcoholism: a new hope?
- Rewiring the brain to fight alcohol cravings?
- Can cash rewards and a breathalyzer app help people stay sober?
- Could a brain hormone curb alcohol cravings and lift depression at the same time?
- Mindfulness may help tame alcohol cravings by reconnecting body and mind